2022-2030 Global and Regional Personalized Cell Therapy Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report Standard Version

Table Of Contents

Chapter 1 Industry Overview

1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2030)
1.4.2 East Asia Market States and Outlook (2022-2030)
1.4.3 Europe Market States and Outlook (2022-2030)
1.4.4 South Asia Market States and Outlook (2022-2030)
1.4.5 Southeast Asia Market States and Outlook (2022-2030)
1.4.6 Middle East Market States and Outlook (2022-2030)
1.4.7 Africa Market States and Outlook (2022-2030)
1.4.8 Oceania Market States and Outlook (2022-2030)
1.4.9 South America Market States and Outlook (2022-2030)
1.5 Global Personalized Cell Therapy Market Size Analysis from 2022 to 2027
1.5.1 Global Personalized Cell Therapy Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Personalized Cell Therapy Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Personalized Cell Therapy Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Personalized Cell Therapy Industry Impact
Chapter 2 Global Personalized Cell Therapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Personalized Cell Therapy (Volume and Value) by Type
2.1.1 Global Personalized Cell Therapy Consumption and Market Share by Type (2017-2022)
2.1.2 Global Personalized Cell Therapy Revenue and Market Share by Type (2017-2022)
2.2 Global Personalized Cell Therapy (Volume and Value) by Application
2.2.1 Global Personalized Cell Therapy Consumption and Market Share by Application (2017-2022)
2.2.2 Global Personalized Cell Therapy Revenue and Market Share by Application (2017-2022)
2.3 Global Personalized Cell Therapy (Volume and Value) by Regions
2.3.1 Global Personalized Cell Therapy Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Personalized Cell Therapy Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Personalized Cell Therapy Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Personalized Cell Therapy Consumption by Regions (2017-2022)
4.2 North America Personalized Cell Therapy Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Personalized Cell Therapy Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Personalized Cell Therapy Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Personalized Cell Therapy Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Personalized Cell Therapy Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Personalized Cell Therapy Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Personalized Cell Therapy Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Personalized Cell Therapy Sales, Consumption, Export, Import (2017-2022)
4.10 South America Personalized Cell Therapy Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Personalized Cell Therapy Market Analysis
5.1 North America Personalized Cell Therapy Consumption and Value Analysis
5.1.1 North America Personalized Cell Therapy Market Under COVID-19
5.2 North America Personalized Cell Therapy Consumption Volume by Types
5.3 North America Personalized Cell Therapy Consumption Structure by Application
5.4 North America Personalized Cell Therapy Consumption by Top Countries
5.4.1 United States Personalized Cell Therapy Consumption Volume from 2016 to 2021
5.4.2 Canada Personalized Cell Therapy Consumption Volume from 2016 to 2021
5.4.3 Mexico Personalized Cell Therapy Consumption Volume from 2016 to 2021
Chapter 6 East Asia Personalized Cell Therapy Market Analysis
6.1 East Asia Personalized Cell Therapy Consumption and Value Analysis
6.1.1 East Asia Personalized Cell Therapy Market Under COVID-19
6.2 East Asia Personalized Cell Therapy Consumption Volume by Types
6.3 East Asia Personalized Cell Therapy Consumption Structure by Application
6.4 East Asia Personalized Cell Therapy Consumption by Top Countries
6.4.1 China Personalized Cell Therapy Consumption Volume from 2016 to 2021
6.4.2 Japan Personalized Cell Therapy Consumption Volume from 2016 to 2021
6.4.3 South Korea Personalized Cell Therapy Consumption Volume from 2016 to 2021
Chapter 7 Europe Personalized Cell Therapy Market Analysis
7.1 Europe Personalized Cell Therapy Consumption and Value Analysis
7.1.1 Europe Personalized Cell Therapy Market Under COVID-19
7.2 Europe Personalized Cell Therapy Consumption Volume by Types
7.3 Europe Personalized Cell Therapy Consumption Structure by Application
7.4 Europe Personalized Cell Therapy Consumption by Top Countries
7.4.1 Germany Personalized Cell Therapy Consumption Volume from 2016 to 2021
7.4.2 UK Personalized Cell Therapy Consumption Volume from 2016 to 2021
7.4.3 France Personalized Cell Therapy Consumption Volume from 2016 to 2021
7.4.4 Italy Personalized Cell Therapy Consumption Volume from 2016 to 2021
7.4.5 Russia Personalized Cell Therapy Consumption Volume from 2016 to 2021
7.4.6 Spain Personalized Cell Therapy Consumption Volume from 2016 to 2021
7.4.7 Netherlands Personalized Cell Therapy Consumption Volume from 2016 to 2021
7.4.8 Switzerland Personalized Cell Therapy Consumption Volume from 2016 to 2021
7.4.9 Poland Personalized Cell Therapy Consumption Volume from 2016 to 2021
Chapter 8 South Asia Personalized Cell Therapy Market Analysis
8.1 South Asia Personalized Cell Therapy Consumption and Value Analysis
8.1.1 South Asia Personalized Cell Therapy Market Under COVID-19
8.2 South Asia Personalized Cell Therapy Consumption Volume by Types
8.3 South Asia Personalized Cell Therapy Consumption Structure by Application
8.4 South Asia Personalized Cell Therapy Consumption by Top Countries
8.4.1 India Personalized Cell Therapy Consumption Volume from 2016 to 2021
8.4.2 Pakistan Personalized Cell Therapy Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Personalized Cell Therapy Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Personalized Cell Therapy Market Analysis
9.1 Southeast Asia Personalized Cell Therapy Consumption and Value Analysis
9.1.1 Southeast Asia Personalized Cell Therapy Market Under COVID-19
9.2 Southeast Asia Personalized Cell Therapy Consumption Volume by Types
9.3 Southeast Asia Personalized Cell Therapy Consumption Structure by Application
9.4 Southeast Asia Personalized Cell Therapy Consumption by Top Countries
9.4.1 Indonesia Personalized Cell Therapy Consumption Volume from 2016 to 2021
9.4.2 Thailand Personalized Cell Therapy Consumption Volume from 2016 to 2021
9.4.3 Singapore Personalized Cell Therapy Consumption Volume from 2016 to 2021
9.4.4 Malaysia Personalized Cell Therapy Consumption Volume from 2016 to 2021
9.4.5 Philippines Personalized Cell Therapy Consumption Volume from 2016 to 2021
9.4.6 Vietnam Personalized Cell Therapy Consumption Volume from 2016 to 2021
9.4.7 Myanmar Personalized Cell Therapy Consumption Volume from 2016 to 2021
Chapter 10 Middle East Personalized Cell Therapy Market Analysis
10.1 Middle East Personalized Cell Therapy Consumption and Value Analysis
10.1.1 Middle East Personalized Cell Therapy Market Under COVID-19
10.2 Middle East Personalized Cell Therapy Consumption Volume by Types
10.3 Middle East Personalized Cell Therapy Consumption Structure by Application
10.4 Middle East Personalized Cell Therapy Consumption by Top Countries
10.4.1 Turkey Personalized Cell Therapy Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Personalized Cell Therapy Consumption Volume from 2016 to 2021
10.4.3 Iran Personalized Cell Therapy Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Personalized Cell Therapy Consumption Volume from 2016 to 2021
10.4.5 Israel Personalized Cell Therapy Consumption Volume from 2016 to 2021
10.4.6 Iraq Personalized Cell Therapy Consumption Volume from 2016 to 2021
10.4.7 Qatar Personalized Cell Therapy Consumption Volume from 2016 to 2021
10.4.8 Kuwait Personalized Cell Therapy Consumption Volume from 2016 to 2021
10.4.9 Oman Personalized Cell Therapy Consumption Volume from 2016 to 2021
Chapter 11 Africa Personalized Cell Therapy Market Analysis
11.1 Africa Personalized Cell Therapy Consumption and Value Analysis
11.1.1 Africa Personalized Cell Therapy Market Under COVID-19
11.2 Africa Personalized Cell Therapy Consumption Volume by Types
11.3 Africa Personalized Cell Therapy Consumption Structure by Application
11.4 Africa Personalized Cell Therapy Consumption by Top Countries
11.4.1 Nigeria Personalized Cell Therapy Consumption Volume from 2016 to 2021
11.4.2 South Africa Personalized Cell Therapy Consumption Volume from 2016 to 2021
11.4.3 Egypt Personalized Cell Therapy Consumption Volume from 2016 to 2021
11.4.4 Algeria Personalized Cell Therapy Consumption Volume from 2016 to 2021
11.4.5 Morocco Personalized Cell Therapy Consumption Volume from 2016 to 2021
Chapter 12 Oceania Personalized Cell Therapy Market Analysis
12.1 Oceania Personalized Cell Therapy Consumption and Value Analysis
12.2 Oceania Personalized Cell Therapy Consumption Volume by Types
12.3 Oceania Personalized Cell Therapy Consumption Structure by Application
12.4 Oceania Personalized Cell Therapy Consumption by Top Countries
12.4.1 Australia Personalized Cell Therapy Consumption Volume from 2016 to 2021
12.4.2 New Zealand Personalized Cell Therapy Consumption Volume from 2016 to 2021
Chapter 13 South America Personalized Cell Therapy Market Analysis
13.1 South America Personalized Cell Therapy Consumption and Value Analysis
13.1.1 South America Personalized Cell Therapy Market Under COVID-19
13.2 South America Personalized Cell Therapy Consumption Volume by Types
13.3 South America Personalized Cell Therapy Consumption Structure by Application
13.4 South America Personalized Cell Therapy Consumption Volume by Major Countries
13.4.1 Brazil Personalized Cell Therapy Consumption Volume from 2016 to 2021
13.4.2 Argentina Personalized Cell Therapy Consumption Volume from 2016 to 2021
13.4.3 Columbia Personalized Cell Therapy Consumption Volume from 2016 to 2021
13.4.4 Chile Personalized Cell Therapy Consumption Volume from 2016 to 2021
13.4.5 Venezuela Personalized Cell Therapy Consumption Volume from 2016 to 2021
13.4.6 Peru Personalized Cell Therapy Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Personalized Cell Therapy Consumption Volume from 2016 to 2021
13.4.8 Ecuador Personalized Cell Therapy Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Personalized Cell Therapy Business
14.1 Novartis AG
14.1.1 Novartis AG Company Profile
14.1.2 Novartis AG Personalized Cell Therapy Product Specification
14.1.3 Novartis AG Personalized Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Vericel Corporation
14.2.1 Vericel Corporation Company Profile
14.2.2 Vericel Corporation Personalized Cell Therapy Product Specification
14.2.3 Vericel Corporation Personalized Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Bellicum Pharmaceuticals
14.3.1 Bellicum Pharmaceuticals Company Profile
14.3.2 Bellicum Pharmaceuticals Personalized Cell Therapy Product Specification
14.3.3 Bellicum Pharmaceuticals Personalized Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 MolMed SpA
14.4.1 MolMed SpA Company Profile
14.4.2 MolMed SpA Personalized Cell Therapy Product Specification
14.4.3 MolMed SpA Personalized Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Cytori Therapeutics Inc
14.5.1 Cytori Therapeutics Inc Company Profile
14.5.2 Cytori Therapeutics Inc Personalized Cell Therapy Product Specification
14.5.3 Cytori Therapeutics Inc Personalized Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Gilead Sciences, Inc
14.6.1 Gilead Sciences, Inc Company Profile
14.6.2 Gilead Sciences, Inc Personalized Cell Therapy Product Specification
14.6.3 Gilead Sciences, Inc Personalized Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Celgene Corporation
14.7.1 Celgene Corporation Company Profile
14.7.2 Celgene Corporation Personalized Cell Therapy Product Specification
14.7.3 Celgene Corporation Personalized Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Bluebird Bio
14.8.1 Bluebird Bio Company Profile
14.8.2 Bluebird Bio Personalized Cell Therapy Product Specification
14.8.3 Bluebird Bio Personalized Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Aurora Biopharma Inc
14.9.1 Aurora Biopharma Inc Company Profile
14.9.2 Aurora Biopharma Inc Personalized Cell Therapy Product Specification
14.9.3 Aurora Biopharma Inc Personalized Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Saneron CCEL Therapeutics，Inc
14.10.1 Saneron CCEL Therapeutics，Inc Company Profile
14.10.2 Saneron CCEL Therapeutics，Inc Personalized Cell Therapy Product Specification
14.10.3 Saneron CCEL Therapeutics，Inc Personalized Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Kuur Therapeutics
14.11.1 Kuur Therapeutics Company Profile
14.11.2 Kuur Therapeutics Personalized Cell Therapy Product Specification
14.11.3 Kuur Therapeutics Personalized Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 MediGene AG
14.12.1 MediGene AG Company Profile
14.12.2 MediGene AG Personalized Cell Therapy Product Specification
14.12.3 MediGene AG Personalized Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Sangamo Therapeutics
14.13.1 Sangamo Therapeutics Company Profile
14.13.2 Sangamo Therapeutics Personalized Cell Therapy Product Specification
14.13.3 Sangamo Therapeutics Personalized Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Personalized Cell Therapy Market Forecast (2022-2030)
15.1 Global Personalized Cell Therapy Consumption Volume, Revenue and Price Forecast (2022-2030)
15.1.1 Global Personalized Cell Therapy Consumption Volume and Growth Rate Forecast (2022-2030)
15.1.2 Global Personalized Cell Therapy Value and Growth Rate Forecast (2022-2030)
15.2 Global Personalized Cell Therapy Consumption Volume, Value and Growth Rate Forecast by Region (2022-2030)
15.2.1 Global Personalized Cell Therapy Consumption Volume and Growth Rate Forecast by Regions (2022-2030)
15.2.2 Global Personalized Cell Therapy Value and Growth Rate Forecast by Regions (2022-2030)
15.2.3 North America Personalized Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.4 East Asia Personalized Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.5 Europe Personalized Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.6 South Asia Personalized Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.7 Southeast Asia Personalized Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.8 Middle East Personalized Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.9 Africa Personalized Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.10 Oceania Personalized Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.11 South America Personalized Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.3 Global Personalized Cell Therapy Consumption Volume, Revenue and Price Forecast by Type (2022-2030)
15.3.1 Global Personalized Cell Therapy Consumption Forecast by Type (2022-2030)
15.3.2 Global Personalized Cell Therapy Revenue Forecast by Type (2022-2030)
15.3.3 Global Personalized Cell Therapy Price Forecast by Type (2022-2030)
15.4 Global Personalized Cell Therapy Consumption Volume Forecast by Application (2022-2030)
15.5 Personalized Cell Therapy Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology